We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer’s disease (AD) and ...

Alzheimer’s disease may cause degeneration of neurons in the brain through amyloid plaques, neurofibrillary tangles, inflammation, and brain atrophy. The condition may affect different parts of ...

Ten years later, they had brain imaging to detect signs related to dementia, when they were 50 or older. The new research, published Wednesday in the journal Neurology, found people with lower ...

Key TakeawaysAn expert workgroup representing primary and specialty care has developed new guidelines for comprehensive evaluation of patients who may ...

Researchers have found that a common virus, which causes a cold-like infection, may be linked to Alzheimer's - but stressed ...

Alzheimer’s disease primarily affects people over the age of 65, but it’s never too early to be aware of the warning signs of this common brain disorder. And you may be able to detect them ...

Alzheimer’s disease is a condition that affects the brain. Symptoms are mild at first and become more severe over time. It is named after Dr. Alois Alzheimer, who first described the condition ...

But for many conditions, from dementia-causing diseases such as Alzheimer’s disease ... brain imaging technologies such as magnetic resonance imaging (MRI) or computed tomography (CT).

Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy. The Lancet Neurology , 2024; 23 (10): 1025 DOI: 10.1016/S1474-4422(24 ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study ...